Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment

NATerminatedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 25, 2017

Study Completion Date

December 25, 2017

Conditions
Mild Cognitive Impairment
Interventions
OTHER

Phosphatidylserine

OTHER

Placebo

Trial Locations (15)

11229

Integrative Clinical Trials, LLC, Brooklyn

18104

Lehigh Center for Clinical Research, Allentown

32803

APG Research LLC, Orlando

33137

Miami Jewish Health Systems, Miami

33613

University of South Florida, Tampa

60640

Great Lakes Clinical Trials, Chicago

80401

New West Physicians, PC, Golden

90720

Pharmacology Research Institute, Los Alamitos

91316

Pharmacology Research Institute, Encino

Unknown

Pharmacology Research Institute, Newport Beach

Rambam medical center, Israel, Haifa

Ichilov medical center, Tel Aviv

07724,

Memory Enhancement Center of America, Eatontown

08540

Princeton Medical Institute, Princeton

10128,

The Medical Research Network, New York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Enzymotec

INDUSTRY